HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neutrogena Study Supports High SPF Labeling; Will FDA Take Off Its Cap?

This article was originally published in The Rose Sheet

Executive Summary

As the release of FDA's final sunscreen monograph looms, Johnson & Johnson is again expressing concern about the agency's proposed cap on sun protection factors cited on product labeling, supporting its position with research comparing two formulas of different SPF values

You may also be interested in...



EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain

With FDA’s final sunscreen monograph reportedly around the corner, a greater percentage of sunscreens garnered the Environmental Working Group’s approval this year than in past market surveys, but the group still has concerns about sunscreen regulation and ingredient safety.

EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain

With FDA’s final sunscreen monograph reportedly around the corner, a greater percentage of sunscreens garnered the Environmental Working Group’s approval this year than in past market surveys, but the group still has concerns about sunscreen regulation and ingredient safety.

FDA re-targets final sunscreen rule for May

According to Department of Health and Human Services' Dec. 7 semi-annual agenda, FDA aims to publish a final monograph for OTC sunscreen products in May. The agency has missed its target before, shooting for September in its summer 2009 agenda (1"The Rose Sheet" June 1, 2009). The final version of the monograph - which would address requirements for UVA protection - initially emerged in 1999 but has been consistently delayed. "FDA believes it is important to public health that we issue a final rule for OTC sunscreens as soon as possible," an FDA spokeswoman wrote in a March 17 e-mail to "The Rose Sheet." The agency is likely to take fire if another summer passes without formal protection standards for sunscreen manufacturers (2"The Rose Sheet" Nov. 24, 2008, In Brief)

Related Content

UsernamePublicRestriction

Register

RS016839

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel